​

Ovid Therapeutics Ownership | Who Owns Ovid Therapeutics?

OverviewForecastRevenueFinancialsChart

Ovid Therapeutics Ownership Summary

Ovid Therapeutics is owned by 132.11% institutional investors, 7.53% insiders. Janus henderson group is the largest institutional shareholder, holding 14.53% of OVID shares. Eventide Healthcare & Life Sciences I is the top mutual fund, with 3.29% of its assets in Ovid Therapeutics shares.

OVID Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockOvid Therapeutics132.11%7.53%-39.65%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group10.71M14.53%$23.73M
Ra capital management10.71M14.53%$23.79M
Affinity asset advisors10.64M14.42%$23.61M
Eventide asset management9.92M13.45%$22.02M
Takeda pharmaceutical7.53M10.59%$9.79M
Adage capital partners gp6.16M8.36%$13.68M
Balyasny asset management5.53M7.50%$12.28M
Saturn v capital management4.17M5.65%$9.25M
Blackrock3.99M5.65%$3.07M
Federated hermes3.57M4.84%$7.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Takeda pharmaceutical7.53M59.82%$9.79M
Saturn v capital management4.17M1.68%$9.25M
Propel bio management921.46K1.28%$2.04M
Affinity asset advisors10.64M1.22%$23.61M
Blue owl capital lp1.90M1.14%$4.23M
Rosalind advisors1.11M0.99%$2.46M
Sphera funds management1.62M0.57%$3.60M
Ikarian capital2.89M0.52%$6.43M
Sio capital management1.25M0.40%$2.78M
Verdad advisers, lp151.92K0.38%$337.26K

Top Buyers

HolderShares% AssetsChange
Janus henderson group10.71M0.01%10.71M
Eventide asset management9.92M0.36%5.63M
Balyasny asset management5.53M0.02%5.21M
Affinity asset advisors10.64M1.22%3.49M
Adage capital partners gp6.16M0.02%2.67M

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---6.12M
Bvf inc/il---3.85M
Siren---2.85M
Point72 asset management1.32M0.00%-2.23M
Madison avenue partners, lp---1.31M

New Positions

HolderShares% AssetsChangeValue
Janus henderson group10.71M0.01%10.71M$23.73M
Blue owl capital lp1.90M1.14%1.90M$4.23M
Sphera funds management1.62M0.57%1.62M$3.60M
Rosalind advisors1.11M0.99%1.11M$2.46M
Silverarc capital management1.00M0.23%1.00M$2.22M

Sold Out

HolderChange
Newedge advisors-4.00
Ifp advisors-8.00
True wealth design-8.00
Nelson, van denburg & campbell wealth management group-10.00
Frazier financial advisors-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202610617.78%97,413,11457.44%1321.74%6036.36%19-24.00%
Dec 31, 202537-55.95%12,969,774-64.18%180.70%15-64.29%9-62.50%
Sep 30, 202526-62.86%6,077,081-83.10%80.33%13-60.61%8-61.90%
Jun 30, 202569-15.85%35,963,757-7.47%2,877297.56%3417.24%21-25.00%
Mar 31, 202583-46,400,658-2.45%370.83%29-21.62%2833.33%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Eventide Healthcare & Life Sciences I4.29M3.29%4.29M
Federated Hermes Kaufmann Small Cap Grow5.36M3.10%5.36M
Vanguard US Total Market Shares ETF1.79M2.52%-
Vanguard Total Stock Mkt Idx Inv3.83M2.29%-
Federated Hermes Kaufmann Small Cap A3.57M2.06%-
Kennedy Micro Cap1.04M1.46%-64.12K
Fidelity Small Cap Index578.63K0.81%-
Vanguard Institutional Extnd Mkt Idx Tr1.33M0.80%601.00
State St Russell Sm/Mid Cp® Indx SL Cl I525.80K0.74%-
State St Russell Sm/Mid Cp® Indx NL Cl C525.80K0.74%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 23, 2026ALEXANDER MARGARET A. President and CEOSell$16.90K
Feb 23, 2026Rona Jeffrey A CBFOSell$12.38K
Dec 11, 2025LEVIN JEREMY M CEOBuy-
Dec 11, 2025LEVIN JEREMY M CEOBuy$66.27K
Dec 11, 2025LEVIN JEREMY M CEOBuy$49.70K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q43-
2025 Q112
2024 Q4--
2024 Q3--

OVID Ownership FAQ

Who Owns Ovid Therapeutics?

Ovid Therapeutics shareholders are primarily institutional investors at 132.11%, followed by 7.53% insiders and -39.64% retail investors. The average institutional ownership in Ovid Therapeutics's industry, Biotech Stocks , is 35.75%, which Ovid Therapeutics exceeds.

Who owns the most shares of Ovid Therapeutics?

Ovid Therapeutics’s largest shareholders are Janus henderson group (10.71M shares, 14.53%), Ra capital management (10.71M shares, 14.53%), and Affinity asset advisors (10.64M shares, 14.42%). Together, they hold 43.49% of Ovid Therapeutics’s total shares outstanding.

Does Blackrock own Ovid Therapeutics?

Yes, BlackRock owns 5.65% of Ovid Therapeutics, totaling 3.99M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 3.07M$. In the last quarter, BlackRock decreased its holdings by -203K shares, a -4.84% change.

Who is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Ovid Therapeutics’s biggest shareholder by percentage of total assets invested, with 59.82% of its assets in 7.53M Ovid Therapeutics shares, valued at 9.79M$.

Who is the top mutual fund holder of Ovid Therapeutics shares?

Eventide Healthcare & Life Sciences I is the top mutual fund holder of Ovid Therapeutics shares, with 3.29% of its total shares outstanding invested in 4.28M Ovid Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools